0 Comments
0 Shares
765 Views
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Oncology Companion Diagnostics Market to Reach USD 3.05 Billion by 2033, Driven by Personalized Cancer TreatmentsMarket Overview The global oncology companion diagnostics market size was valued at USD 1116.73 Million in 2024 and is projected to grow from USD 1248.51 Million in 2025 to reach USD 3047.37 Million by 2033, exhibiting a CAGR of 11.8% during the forecast period (2025–2033). The global Oncology Companion Diagnostics market is witnessing swift...0 Comments 0 Shares 672 Views
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations in the...0 Comments 0 Shares 886 Views
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations...0 Comments 0 Shares 886 Views
-
Why Is North America Leading Innovation in CTC Liquid Biopsy Technologies?"Executive Summary North America Circulating Tumor Cells (CTC) Liquid Biopsy Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the market is growing with a CAGR of 25.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,650.96 million by 2029 from USD 442.64 million in 2021. The key topics that have been described in this...0 Comments 0 Shares 798 Views